Literature DB >> 13303120

Novobiocin; a limited bacteriologic and clinical study of its use in forty-five patients.

R L NICHOLS, M FINLAND.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapeutic use; MICROCOCCAL INFECTIONS/therapy; URINARY TRACT/infections

Mesh：

Substances：

Year:  1956        PMID： 13303120

Source DB:  PubMed          Journal:  Antibiotic Med Clin Ther (New York)        ISSN： 0570-3107


× No keyword cloud information.
  12 in total

1.  Hospital infection yesterday and today.

Authors:  M BARBER
Journal:  J Clin Pathol       Date:  1961-01       Impact factor: 3.411

2.  Staphylococcal infection resistant to chloramphenicol, erythromycin, and novobiocin; effect of antibiotic combinations on the emergence of resistant strains.

Authors:  M BARBER; A CSILLAG; A J MEDWAY
Journal:  Br Med J       Date:  1958-12-06

3.  Antibiotics versus Staphylococci.

Authors: 
Journal:  Br Med J       Date:  1956-07-28

4.  Novobiocin, a New Antibiotic.

Authors:  S J Shane
Journal:  Can Med Assoc J       Date:  1956-07-01       Impact factor: 8.262

5.  Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates.

Authors:  E G Arathoon; J R Hamilton; C E Hench; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.

Authors:  G L Drusano; R J Townsend; T J Walsh; A Forrest; E J Antal; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

7.  Effect of novobiocin and its combination with tetracycline, chloramphenicol, erythromycin, and lincomycin on the microbial generation of Escherichia coli.

Authors:  E R Garrett; C M Won
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

8.  A systematic protocol for the characterization of Hsp90 modulators.

Authors:  Robert L Matts; Gary E L Brandt; Yuanming Lu; Anshuman Dixit; Mehdi Mollapour; Suiquan Wang; Alison C Donnelly; Leonard Neckers; Gennady Verkhivker; Brian S J Blagg
Journal:  Bioorg Med Chem       Date:  2010-10-19       Impact factor: 3.641

9.  In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.

Authors:  P French; E Venuti; H S Fraimow
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 10.  Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.

Authors:  Gary E L Brandt; Brian S J Blagg
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.